103 related articles for article (PubMed ID: 18664394)
41. l-Tryptophan exhibits therapeutic function in a porcine model of dextran sodium sulfate (DSS)-induced colitis.
Kim CJ; Kovacs-Nolan JA; Yang C; Archbold T; Fan MZ; Mine Y
J Nutr Biochem; 2010 Jun; 21(6):468-75. PubMed ID: 19428234
[TBL] [Abstract][Full Text] [Related]
42. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury.
Froicu M; Cantorna MT
BMC Immunol; 2007 Mar; 8():5. PubMed ID: 17397543
[TBL] [Abstract][Full Text] [Related]
43. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.
Tamaki H; Nakamura H; Nishio A; Nakase H; Ueno S; Uza N; Kido M; Inoue S; Mikami S; Asada M; Kiriya K; Kitamura H; Ohashi S; Fukui T; Kawasaki K; Matsuura M; Ishii Y; Okazaki K; Yodoi J; Chiba T
Gastroenterology; 2006 Oct; 131(4):1110-21. PubMed ID: 17030181
[TBL] [Abstract][Full Text] [Related]
44. An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Kuroda M; Katada K; Ichikawa H; Kokura S; Yoshida N; Okanoue T; Yoshikawa T
Inflamm Res; 2004 Sep; 53(9):462-8. PubMed ID: 15550999
[TBL] [Abstract][Full Text] [Related]
45. Endogenous regulation of visceral pain via production of opioids by colitogenic CD4(+) T cells in mice.
Boué J; Basso L; Cenac N; Blanpied C; Rolli-Derkinderen M; Neunlist M; Vergnolle N; Dietrich G
Gastroenterology; 2014 Jan; 146(1):166-75. PubMed ID: 24055279
[TBL] [Abstract][Full Text] [Related]
46. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
Aharoni R
J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
[TBL] [Abstract][Full Text] [Related]
47. Novel immunomodulatory properties of cirsilineol through selective inhibition of IFN-gamma signaling in a murine model of inflammatory bowel disease.
Sun Y; Wu XX; Yin Y; Gong FY; Shen Y; Cai TT; Zhou XB; Wu XF; Xu Q
Biochem Pharmacol; 2010 Jan; 79(2):229-38. PubMed ID: 19698701
[TBL] [Abstract][Full Text] [Related]
48. Oral administration of Lactobacillus paracasei alleviates clinical symptoms of colitis induced by dextran sulphate sodium salt in BALB/c mice.
Pan T; Guo HY; Zhang H; Liu AP; Wang XX; Ren FZ
Benef Microbes; 2014 Sep; 5(3):315-22. PubMed ID: 24889889
[TBL] [Abstract][Full Text] [Related]
49. Nicotine suppresses acute colitis and colonic tumorigenesis associated with chronic colitis in mice.
Hayashi S; Hamada T; Zaidi SF; Oshiro M; Lee J; Yamamoto T; Ishii Y; Sasahara M; Kadowaki M
Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G968-78. PubMed ID: 25258409
[TBL] [Abstract][Full Text] [Related]
50. Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis.
Chu CC; Hou YC; Pai MH; Chao CJ; Yeh SL
J Nutr Biochem; 2012 Sep; 23(9):1092-9. PubMed ID: 22137260
[TBL] [Abstract][Full Text] [Related]
51. The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease.
Mencarelli A; Renga B; Palladino G; Distrutti E; Fiorucci S
Biochem Pharmacol; 2009 Nov; 78(9):1214-23. PubMed ID: 19555671
[TBL] [Abstract][Full Text] [Related]
52. New prebiotics from rice bran ameliorate inflammation in murine colitis models through the modulation of intestinal homeostasis and the mucosal immune system.
Komiyama Y; Andoh A; Fujiwara D; Ohmae H; Araki Y; Fujiyama Y; Mitsuyama K; Kanauchi O
Scand J Gastroenterol; 2011 Jan; 46(1):40-52. PubMed ID: 20735154
[TBL] [Abstract][Full Text] [Related]
53. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice.
Obermeier F; Dunger N; Deml L; Herfarth H; Schölmerich J; Falk W
Eur J Immunol; 2002 Jul; 32(7):2084-92. PubMed ID: 12115630
[TBL] [Abstract][Full Text] [Related]
54. Vasoactive Intestinal Peptide Nanomedicine for the Management of Inflammatory Bowel Disease.
Jayawardena D; Anbazhagan AN; Guzman G; Dudeja PK; Onyuksel H
Mol Pharm; 2017 Nov; 14(11):3698-3708. PubMed ID: 28991483
[TBL] [Abstract][Full Text] [Related]
55. Transforming growth factor-beta messenger RNA and protein in murine colitis.
Whiting CV; Williams AM; Claesson MH; Bregenholt S; Reimann J; Bland PW
J Histochem Cytochem; 2001 Jun; 49(6):727-38. PubMed ID: 11373319
[TBL] [Abstract][Full Text] [Related]
56. Anti-CD81 antibodies reduce migration of activated T lymphocytes and attenuate mouse experimental colitis.
Hasezaki T; Yoshima T; Mine Y
Sci Rep; 2020 Apr; 10(1):6969. PubMed ID: 32332834
[TBL] [Abstract][Full Text] [Related]
57. Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis.
Newman R; Cuan N; Hampartzoumian T; Connor SJ; Lloyd AR; Grimm MC
Clin Exp Immunol; 2005 Mar; 139(3):411-20. PubMed ID: 15730386
[TBL] [Abstract][Full Text] [Related]
58. Oral Delivery of Particulate Transforming Growth Factor Beta 1 and All-Trans Retinoic Acid Reduces Gut Inflammation in Murine Models of Inflammatory Bowel Disease.
Conway TF; Hammer L; Furtado S; Mathiowitz E; Nicoletti F; Mangano K; Egilmez NK; Auci DL
J Crohns Colitis; 2015 Aug; 9(8):647-58. PubMed ID: 25987350
[TBL] [Abstract][Full Text] [Related]
59. Human Mesenchymal Stem Cell-Treated Regulatory CD23
Chen X; Cai C; Xu D; Liu Q; Zheng S; Liu L; Li G; Zhang X; Li X; Ma Y; Huang L; Chen J; Shi J; Du X; Xia W; Xiang AP; Peng Y
Theranostics; 2019; 9(16):4633-4647. PubMed ID: 31367246
[No Abstract] [Full Text] [Related]
60. Thrombospondin-1 type 1 repeats in a model of inflammatory bowel disease: transcript profile and therapeutic effects.
Lopez-Dee ZP; Chittur SV; Patel B; Stanton R; Wakeley M; Lippert B; Menaker A; Eiche B; Terry R; Gutierrez LS
PLoS One; 2012; 7(4):e34590. PubMed ID: 22509329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
